Last updated 2026-06-18
- Raised $8M funding round, Sep 2017
Total raised
$8.0M
Last: 2017-09
Stage
Series A
Founded
2005
Headcount
8
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
About
LipoCure is developing a number of therapeutics utilizing proprietary liposome-based nano drugs with novel drug-loading capabilities and drug-release mechanisms. LipoCure's proprietary platform implements an approach that allows for remote drug loading into nano-liposomes and concomitant controlled release of the drugs at the targeted site. This technology is designed to produce an enhanced permeability and retention effect, a significantly improved therapeutic effect, and reduced side effects. It can be used in conjunction with several well-established drugs used for the treatment of rheumatoid arthritis, multiple sclerosis, and cancer. LipoCure's founder is professor Yechezkel Barenholz, the co-developer of Doxil.
Funding history · 1 round · $8.0M total
2017-09
Q&A
- What is LipoCure's primary focus?
- LipoCure is developing therapeutics using proprietary liposome-based nano drugs with novel drug-loading and release mechanisms.
- When was LipoCure founded?
- LipoCure was founded in November 2005.
- Where is LipoCure headquartered?
- LipoCure is headquartered in Jerusalem, Jerusalem District, Israel.
- Who is the founder of LipoCure?
- Professor Yechezkel Barenholz is the founder of LipoCure and also serves as its CSO. He is known as the co-developer of Doxil.
- How much funding has LipoCure raised in total?
- LipoCure has raised a total of $8,000,000 USD.
- When was LipoCure's last funding round and who were the investors?
- LipoCure's last funding round occurred in September 2017, with investments from Integra Holdings and Yechezkel Barenholz.
- What is LipoCure's current product stage?
- LipoCure's product is currently in the clinical trial stage.
Team · 1
Founder · CSO and Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
Materials & SubstancesNanomaterials
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
oncologynanotechnologyinflammatory-diseasespharmaceuticalsmedical-technologiessustained-releaseimmunotherapydrug-deliverypharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | lipocurerx.com/ |
|---|---|
| linkedin.com/company/3738990 |
Identifiers & details
| Founded | 2005-11 |
|---|---|
| Employees (exact) | 8 |
Radar intelligence
Publications (Crossref)
| Works | 1 |
|---|
Web history (Wayback)
| Domain | lipocurerx.com |
|---|
Certificate / subdomain footprint
| Subdomains | 8 |
|---|